Crossmark

Rho-kinase inhibition reduces systolic blood pressure and forearm vascular resistance in healthy older adults: a double-blind, randomized, placebo-controlled pilot study

Crossref DOI link: https://doi.org/10.1007/s11357-024-01240-x

Published Online: 2024-06-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bachman, Nate P.

Ketelhut, Nathaniel B.

Blomquist, Michael

Terwoord, Janée D. https://orcid.org/0000-0003-1224-999X
Funding

Funding for this research was provided by:

Foundation for the National Institutes of Health (R01HL119337, F31HL142240)
License Information

Text and Data Mining valid from 2024-06-18

Version of Record valid from 2024-06-18
More Information

Article History

Received: 19 April 2024

Accepted: 4 June 2024

First Online: 18 June 2024

Declarations

:

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below